Progress in application of alveolar exhaled nitric oxide in pediatric lung diseases / 国际儿科学杂志
International Journal of Pediatrics
; (6): 274-278, 2022.
Article
em Zh
| WPRIM
| ID: wpr-929848
Biblioteca responsável:
WPRO
ABSTRACT
As a biomarker of airway inflammation, alveolar exhaled nitric oxide(CaNO), which represents small airway inflammation, is increasingly used in respiratory diseases.CaNO not only can be applied to children bronchial asthma severity evaluation, the selection of treatment and treatment effect of the dynamic monitoring, can also be applied to the early diagnosis of interstitial lung disease and assessment of the severity of lung damage for other diseases such as tuberculosis, pulmonary hypertension diagnosis.This paper reviews the diagnostic and therapeutic value of CaNO in pediatric respiratory diseases, and discusses the role of CaNO in the diagnosis and therapeutic evaluation in pediatric lung diseases.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Screening_studies
Idioma:
Zh
Revista:
International Journal of Pediatrics
Ano de publicação:
2022
Tipo de documento:
Article